Position in TVTX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$26,897,033
+$1,442,784 QoQ
Shares Held
473,456
-44.7% QoQ
Ownership
0.502%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#40
of 317 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 95%
Shared 0%
None 5%
Common Shares in TVTX Over Time
Shares Held
Position Value (USD)
Derivatives in TVTX
reported options exposure · as of Sep 30, 2025CallValue
$2,464,090
CallShares
103,100
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026UBS Group AG holds $8,751,270,183 across 562 Biotechnology names. TVTX ranks #59 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
5,450,825 | $1,020,369,609 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
17,466,641 | $618,144,423 | |
| 3 | PTGX |
Protagonist Therapeutics, Inc
|
3,399,221 | $416,676,508 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
712,259 | $353,800,411 | |
| 5 | MRNA |
Moderna, Inc.
|
4,463,211 | $312,558,664 | |
| 6 | INSM |
INSMED Inc
|
2,584,446 | $275,553,630 | |
| 7 | ABVX |
Abivax S.A.
|
1,844,918 | $245,853,771 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
401,708 | $215,697,109 |
All Filings in TVTX
Export CSV
34 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $26,897,033 | 473,456 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $25,454,249 | 856,757 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $16,148,271 | 422,619 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $11,784,443 | 493,073 | Shares | Defined | 2025-11-13 | |
| 2025-09-30 | $2,464,090 | 103,100 | Call | Defined | 2025-11-13 | |
| 2025-06-30 | $1,805,600 | 122,000 | Call | Defined | 2025-08-14 | |
| 2025-06-30 | $9,624,158 | 650,281 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $3,092,992 | 172,600 | Call | Defined | 2025-05-13 | |
| 2025-03-31 | $12,633,472 | 704,993 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $12,356,997 | 709,357 | Shares | Defined | 2025-02-14 | |
| 2024-12-31 | $3,006,692 | 172,600 | Call | Defined | 2025-02-14 | |
| 2024-09-30 | $4,564,026 | 326,235 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $1,080,979 | 131,506 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $2,872,830 | 372,611 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $1,513,916 | 168,400 | Call | Defined | 2024-02-09 | |
| 2023-12-31 | $1,586,555 | 176,480 | Shares | Defined | 2024-02-09 | |
| 2023-12-31 | $606,825 | 67,500 | Put | Defined | 2024-02-09 | |
| 2023-09-30 | $1,246,236 | 139,400 | Put | Defined | 2023-11-09 | |
| 2023-09-30 | $1,038,828 | 116,200 | Call | Defined | 2023-11-09 | |
| 2023-09-30 | $654,273 | 73,185 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $1,433,088 | 93,300 | Put | Defined | 2023-08-11 | |
| 2023-06-30 | $2,078,544 | 135,322 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $2,828,903 | 125,785 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $4,418,696 | 210,114 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $1,041,680 | 42,276 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $2,465,790 | 101,766 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $3,950,953 | 153,316 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $5,096,953 | 164,206 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $14,525 | 599 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $208,986 | 14,324 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $1,255,540 | 50,282 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $38,756 | 1,422 | Shares | Defined | 2021-02-11 | |
| 2020-06-30 RTRX | — | 237 | Shares | Defined | 2020-07-31 | |
| 2020-03-31 RTRX | — | 10,625 | Shares | Sole | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||